市場調查報告書

細胞培養市場 - 成長,趨勢,預測

Cell Culture Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922038
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
細胞培養市場 - 成長,趨勢,預測 Cell Culture Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 114 Pages
簡介

本報告提供細胞培養的世界市場調查,提供市場概要,各類型,用途,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭力的強度

第5章 市場區隔

  • 各產品
    • 生物安全性設備
    • 離心分離器
    • 凍結保存器
    • 培養系統
    • 培養箱
    • 移液儀器
  • 各消耗品
    • 媒體
    • sera
    • 試劑
  • 各用途
    • 生物醫藥品
    • 醫藥品開發
    • 基因治療
    • 組織培養·工程
    • 疫苗生產
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Biospherix
    • CellGenix GmbH
    • Hi-Media Laboratories
    • Merck KGaA
    • Promocell GmbH
    • Sartorius AG
    • Thermo Fisher Scientific
    • GE Healthcare
    • Sekisui XenoTech, LLC
    • ANGUS Chemical Company

第7章 市場機會及未來趨勢

目錄
Product Code: 67166

Market Overview

The market for cell culture is driven by factors such as rising demand for vaccines, artificial organs and biopharmaceuticals, and growing focus on personalized medicine.

Immunization is the most valuable and cost-effective intervention that delivers better health as well as social and economic benefits. Annually, around 2 to 3 million child deaths and 600,000 adult deaths are prevented with the help of vaccines across the globe. Vaccination programs provide a better return on investments which is augmenting the demand for vaccines. Furthermore, the prevalence of immunity-related diseases is increasing across the globe which is accelerating the growth of vaccine programs resulting in high usage of cell cultures.

In addition, there is a growing demand for personalized medicine across major developed economies. Technological advancements have helped the researchers to come up with novel therapies that can help treat life-threatening diseases. For vaccines as well as personalized medicine, there is mandatory use of cell culture. Hence, the market for cell culture is positively impacted due to the aforementioned factors.

Scope of the Report

As per the scope of the report cell culture is the process of growing the cell under certain controlled conditions outside their natural environment. Once the cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. The market is segmented by product, consumables, application, and geography.

Key Market Trends

Drug Development Segment to Witness Rapid Growth

Cell culture is an integral part of medical research and drug discovery. The two-dimensional (2D) culture has been the preferred method for many decades, due to the ease with which cell monolayers can be induced to proliferate on planar surfaces. The cell culture industry has witnessed evolution and currently, there has been an emergence of 3D cell culture in the market. Drug development is a time taking and costly procedure that is finished in multiple stages from target identification to lead discovery and optimization, preclinical validation and clinical trials culminating in approval for clinical use. Currently, cell-based High Throughput Screening (HTS) is being carried out on cultured cells propagated in two-dimensions (2D) on plastic surfaces optimized for tissue culture. With the emergence of 3D cell culture, the process of HTS has become easier and accurate.

Added to the benefits of cell culture, there is a growing drug discovery being done across the globe which is augmenting the growth of the market.

North America Dominates the Market

North America is currently dominating the cell culture market and is expected to follow the same trend over the forecast period. This is majorly attributed to the growing demand for personalized medicine and the presence of key players in the market. Added to that, the United States government is supportive in terms of medical research as healthcare is one of the major priorities in the country. With the rising focus on cell-based research, it is believed that there will be more technological advancements in the field and this will impact the United States market in a positive manner.

Competitive Landscape

The cell culture market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Becton Dickinson and Company. Thermo Fisher Scientific, Merck KGaA, Sartorius AG, etc. are in turn, increasing the overall competitive rivalry of the market. The product advancements and improvements in cell culture platforms by the major players are increasing the competition.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Demand for Vaccines, Biopharmaceuticals and Artificial Organs
    • 4.2.2 Growing Focus on Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 High Cost Assicated With Cell Based Research
    • 4.3.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Biosafety Equipment
    • 5.1.2 Centrifuges
    • 5.1.3 Cryostorage Equipment
    • 5.1.4 Culture Systems
    • 5.1.5 Incubators
    • 5.1.6 Pipetting Instruments
  • 5.2 By Consumables
    • 5.2.1 Media
    • 5.2.2 Sera
    • 5.2.3 Reagents
  • 5.3 By Application
    • 5.3.1 Biopharmaceuticals
    • 5.3.2 Drug Development
    • 5.3.3 Gene Therapy
    • 5.3.4 Tissue Culture & Engineering
    • 5.3.5 Vaccine Production
    • 5.3.6 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biospherix
    • 6.1.2 CellGenix GmbH
    • 6.1.3 Hi-Media Laboratories
    • 6.1.4 Merck KGaA
    • 6.1.5 Promocell GmbH
    • 6.1.6 Sartorius AG
    • 6.1.7 Thermo Fisher Scientific
    • 6.1.8 GE Healthcare
    • 6.1.9 Sekisui XenoTech, LLC
    • 6.1.10 ANGUS Chemical Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS